Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung cancer (START): A randomized, double-blind, phase III trial

Michael DeGregorio, Lin Soe, Michael Wolf

Research output: Contribution to journalArticle

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)571-573
Number of pages3
JournalJournal of Thoracic Disease
Volume6
Issue number6
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this